Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Glioma
• Giant Cell Glioblastoma
• Glioblastoma
• High-grade Glioma
• Malignant Glioma

Drugs mentioned

• G207 (Herpes simplex virus type 1 G207)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Neoplasms, High Grade Glioma | Phase 2 | Status: WITHDRAWN